The FDA approved oral semaglutide (Wegovy) for weight loss and reducing major adverse cardiovascular events. Novo Nordisk ...

Expanding bispecific antibody access for multiple myeloma involves collaboration between academic centers and community ...

AI innovations, such as the ASCO Guidelines Assistant, enhance evidence-based decision-making by providing quick access to ...

Martha Gulati, MD, explains how bias and underrepresentation in research lead to misdiagnosis of HFpEF in women and delays in ...

Experts discuss the evolving role of bispecific antibodies in multiple myeloma, highlighting treatment advancements and ...

Here are the top 5 most-read pulmonary fibrosis articles of 2025.

Panelists discuss how APPs adapt their roles to meet the operational needs of their institutions—taking on diagnostic ...

Panelists discuss how factors like poverty, unstable housing, limited education, and lack of access to health care contribute ...

Chronic kidney disease significantly impacts cardiovascular health, highlighting the need for effective screening and ...

This is a critical time in IgAN care as growing awareness of the disease, advances in risk stratification, and the emergence ...

Follicular lymphoma is often underrecognized not only for its clinical complexity but also for the significant financial ...

Panelists discuss how evidence-based, patient-tailored guideline adherence enhances long-term schizophrenia outcomes.